Background Mild cognitive impairment (MCI) due to Alzheimer's disease is the symptomatic
predementia phase of Alzheimer's disease dementia, characterised by cognitive and …

Atrophy of the medial temporal lobe, especially the hippocampus and the parahippocampal
gyrus, is considered to be the most predictive structural brain biomarker for Alzheimer's …

Most of the previous task functional magnetic resonance imaging (fMRI) studies found
abnormalities in distributed brain regions in mild cognitive impairment (MCI) and Alzheimer's …

In the literature it is commonly reported that several spatial abilities decline with normal
aging, even though such a decline is not uniform. So far, it is not yet clear which spatial …

Background Mild cognitive impairment (MCI) depicts a transitory phase between healthy
elderly and the onset of Alzheimer's disease (AD) with worsening cognitive impairment …

Repetitive transcranial magnetic stimulation (rTMS) is a non-invasive neuromodulation
technique that is used against cognitive impairment in mild cognitive impairment (MCI) and …

Mild cognitive impairment (MCI) represents a cognitive state intermediate between normal
aging and early Alzheimer's disease (AD). To investigate if the molecular signature of MCI …

In recent years, the focus of research on Alzheimer's disease (AD) has shifted toward finding
reliable diagnostic biomarkers that enable accurate detection of mild cognitive impairment …

The population of elderly adults in the US is growing, and the prevalence of age-related
cognitive decline and dementia is expected to increase in turn. Effective and inexpensive …

Mild cognitive impairment (MCI), and the amnestic subtype of MCI in particular, is the most
recent concept used to describe the intermediary state between healthy aging and …